Literature DB >> 27732125

Undermining Value-Based Purchasing - Lessons from the Pharmaceutical Industry.

Leemore S Dafny1, Christopher J Ody1, Matthew A Schmitt1.   

Abstract

Mesh：

Year:  2016        PMID： 27732125     DOI： 10.1056/NEJMp1607378

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Pharmacy Benefit Management Companies: Do They Create Value in the US Healthcare System?

Authors:  Alan Lyles
Journal:  Pharmacoeconomics       Date:  2017-05       Impact factor: 4.981

2.  Private provision of social insurance: drug-specific price elasticities and cost sharing in Medicare Part D.

Authors:  Liran Einav; Amy Finkelstein; Maria Polyakova
Journal:  Am Econ J Econ Policy       Date:  2018-08

3.  Use of Charity Financial Assistance for Novel Oral Anticancer Agents.

Authors:  Adam J Olszewski; Andrew R Zullo; Christopher R Nering; Justin P Huynh
Journal:  J Oncol Pract       Date:  2018-02-13       Impact factor: 3.840

4.  Association of Reference Pricing with Drug Selection and Spending.

Authors:  James C Robinson; Christopher M Whaley; Timothy T Brown
Journal:  N Engl J Med       Date:  2017-08-17       Impact factor: 91.245

5.  Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries.

Authors:  Ya-Chen Tina Shih; Ying Xu; Lei Liu; Fabrice Smieliauskas
Journal:  J Clin Oncol       Date:  2017-05-04       Impact factor: 44.544

6.  Ophthalmic Medication Expenditures and Out-of-Pocket Spending: An Analysis of United States Prescriptions from 2007 through 2016.

Authors:  Evan M Chen; Ninani Kombo; Christopher C Teng; Prithvi Mruthyunjaya; Kristen Nwanyanwu; Ravi Parikh
Journal:  Ophthalmology       Date:  2020-04-28       Impact factor: 14.277
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.